Impact of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study

Patients receiving N-acetyl-l-cysteine (NAC) during hospitalisation for #SARSCoV2 pneumonia and discharged alive present a significantly shorter length of hospital stay compared to those who did not receive NAC https://bit.ly/3l1QsVo

Detalles Bibliográficos
Autores principales: Faverio, Paola, Rebora, Paola, Rossi, Emanuela, Del Giudice, Savino, Montanelli, Filippo, Garzillo, Laura, Busnelli, Sara, Luppi, Fabrizio, Valsecchi, Maria Grazia, Pesci, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646003/
https://www.ncbi.nlm.nih.gov/pubmed/35136824
http://dx.doi.org/10.1183/23120541.00542-2021
Descripción
Sumario:Patients receiving N-acetyl-l-cysteine (NAC) during hospitalisation for #SARSCoV2 pneumonia and discharged alive present a significantly shorter length of hospital stay compared to those who did not receive NAC https://bit.ly/3l1QsVo

Ejemplares similares